5-Amino-1MQ

5-Amino-1MQ is a small molecule drug designed to inhibit the enzyme nicotinamide N-methyltransferase (NNMT). Key points:

• Chemical formula: C10H11N2+
• Structure: Quinoline ring with an amino group at position 5 and a methyl group at position 1
• Developed as a selective NNMT inhibitor
• Primarily studied for its effects on metabolism and weight loss
• Not FDA-approved; currently used in research settings

5-Amino-1MQ works through several mechanisms:

• 1 Inhibits NNMT, an enzyme predominantly active in fat tissue
• 2 Increases nicotinamide adenine dinucleotide (NAD+) levels
• 3 Activates sirtuin-1 (SIRT1), also known as "the longevity gene"
• 4 Enhances cellular metabolism and energy expenditure
• 5 Promotes fat burning while preserving muscle mass
• 6 Regulates energy expenditure in fat cells
• 7 May increase NAD+ and S-adenosyl methionine (SAM) concentrations in fat cells

• Promotes fat loss while preserving muscle mass
• May reverse diet-induced obesity
• Enhances metabolic rate and fat burning

• Potential treatment for type 2 diabetes and metabolic syndrome
• May improve insulin sensitivity
• Could lower cholesterol levels and improve blood sugar control

• Enhances aged muscle regeneration
• May promote muscle growth and recovery
• Potential benefits for sarcopenia (age-related muscle loss)

• Shows promise in combating various cancer types
• May disrupt energy supply to cancer cells
• Potential to enhance effectiveness of cancer therapies

• Activates SIRT1, associated with longevity
• May have anti-inflammatory properties
• Potential to improve overall healthspan

• Typical dose: 50-150 mg per day
• Often divided into 1-3 doses

• Higher dose: 100-150 mg per day
• Usually divided into 1-2 doses

• Dose range in animal studies: 10-150 mg/kg/day
• Human equivalent doses not established

• No mixing required for oral capsules
• For research purposes, may be reconstituted with appropriate solvents
• Always follow manufacturer's instructions for handling and administration

• Most common method for human use
• Take capsules on an empty stomach
• May be taken once daily or divided into multiple doses

• Used in animal studies
• Not typically used in human applications

• NAD+ boosters
• Other metabolic enhancers
• Exercise regimens for enhanced fat loss

Always research potential interactions before combining substances.

5-Amino-1MQ is primarily available for research purposes. It's crucial to source from reputable suppliers that provide certificates of analysis and third-party testing results.

Generally considered to have a favorable safety profile in animal studies:

• No significant adverse effects reported in preclinical trials
• Human safety data is limited

Potential side effects may include:

• Nausea
• Headache
• Increased appetite (due to increased metabolic rate)

• Not approved by the FDA for human use
• Legal status varies by country and jurisdiction
• Often restricted to research or medical use
• In the US, it's legal to possess for research purposes but not for human consumption
• Always check local laws before purchasing or using 5-Amino-1MQ

• Store in a cool, dry place away from direct light
• Keep at room temperature (20-25°C or 68-77°F)
• Protect from moisture
• Keep out of reach of children
• Use within the expiration date

Effects may vary, but some users report noticeable changes in energy levels and metabolism within 2-4 weeks of consistent use.

While not primarily designed for bodybuilding, its potential to preserve muscle mass during fat loss may be beneficial for body composition goals.

Long-term safety data in humans is limited. More research is needed to establish its safety profile for extended use.

Yes, ipamorelin can be used by women. Some studies suggest it may be particularly beneficial for postmenopausal women in terms of body composition and bone density. However, it should not be used during pregnancy or breastfeeding.

5-Amino-1MQ's unique mechanism of NNMT inhibition sets it apart from many traditional weight loss supplements, potentially offering metabolic benefits beyond simple calorie reduction.

• 5-Amino-1MQ shows promise as a novel compound for metabolic health, weight management, and potentially anti-aging applications. The typical dosage range of 50-150 mg per day appears effective for most research applications. Its unique mechanism of NNMT inhibition offers a new approach to tackling obesity and metabolic disorders.However, its use should be approached cautiously due to limited long-term human safety data and varying legal status worldwide. As with any experimental compound, thorough research and professional consultation are essential before use. The potential of 5-Amino-1MQ in weight management, metabolic health, and age-related conditions warrants further investigation, particularly in larger, long-term human trials.

• 1 Neelakantan H, et al. (2019). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology, 164, 165-180.
• 2 Kannt A, et al. (2018). A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Scientific Reports, 8(1), 3660.
• 3 Kraus D, et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature, 508(7495), 258-262.
• 4 Hong S, et al. (2015). Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine, 21(8), 887-894.
• 5 Ulanovskaya OA, et al. (2013). NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nature Chemical Biology, 9(5), 300-306.